These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2626099)

  • 1. [In vitro activities of aztreonam and sulbactam/ampicillin for gram-negative bacteria].
    Ozkuyumcu C; Durupinar B; Dikmen N
    Mikrobiyol Bul; 1989 Jan; 23(1):77-9. PubMed ID: 2626099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the in vitro effectiveness of sulbactam/ampicillin and ampicillin].
    Baykal M; Akalin E
    Mikrobiyol Bul; 1987 Jan; 21(1):16-9. PubMed ID: 3441224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of aztreonam, cefoperazone and ceftriaxone against gram-negative bacteria].
    Baykal M; Hasçelik G
    Mikrobiyol Bul; 1990 Jul; 24(3):248-50. PubMed ID: 2283976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.
    Pfaller MA; Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):356-62. PubMed ID: 8354303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of cefoperazone and cefoperazone-sulbactam against gram-positive and gram-negative bacteria].
    Baykal M; Hasçelik G
    Mikrobiyol Bul; 1990 Oct; 24(4):383-5. PubMed ID: 2287298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefoperazone-sulbactam: Singapore experience.
    Kumarasinghe G; Chow C; Chiu C; Cheong YM
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H; Heizmann W; Heilmann F
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the human oropharyngeal microflora related to therapy with aztreonam, moxalactam and ampicillin plus sulbactam.
    Heimdahl A; Kager L; Nord CE
    Scand J Infect Dis; 1986; 18(1):49-52. PubMed ID: 3008310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
    Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
    Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of beta-lactamase inhibitor sulbactam plus ampicillin against animal isolates of Pasteurella, Haemophilus, and Staphylococcus.
    Girard AE; Schelkly WU; Murphy KT; Sawyer PS
    Am J Vet Res; 1987 Dec; 48(12):1678-83. PubMed ID: 3501686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
    Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
    Monaci E; Monaci R; Giacalone G; Meoni S
    Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association experiments in antimicrobial susceptibility testing of aerobes and anaerobes to ampicillin and ampicillin plus sulbactam.
    Heizmann WR; Werner H; Heilmann F
    J Chemother; 1989 Jul; 1(4 Suppl):315-6. PubMed ID: 16312418
    [No Abstract]   [Full Text] [Related]  

  • 18. In-vitro activity of sulbactam-ampicillin combination.
    Moosdeen F; Lim VK
    Malays J Pathol; 1987 Aug; 9():85-8. PubMed ID: 3133528
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of sulbactam-ampicillin on renal function].
    Kaya IS; Dilmen U
    Mikrobiyol Bul; 1987 Jul; 21(3):178-80. PubMed ID: 3503960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.